A User's Guide to De-escalating Immunomodulator and Biologic Therapy in Inflammatory Bowel Disease.

Hirten, Robert P; Lakatos, Peter L; Halfvarson, Jonas; Colombel, Jean Frederic

Hirten, Robert P; Lakatos, Peter L; Halfvarson, Jonas; Colombel, Jean Frederic.

Afiliación

Hirten RP; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: robert.hirten@mountsinai.org.
Lakatos PL; Division of Gastroenterology, McGill University Health Centre, Montreal, Quebec, Canada; 1st Department of Medicine, Semmelweis University, Budapest, Hungary.
Halfvarson J; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Colombel JF; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.

Clin Gastroenterol Hepatol ; 18(6): 1336-1345, 2020 05.

Article en En | MEDLINE | ID: mdl-31887444

Asunto(s)

Colitis Ulcerosa; Enfermedad de Crohn; Enfermedades Inflamatorias del Intestino; Terapia Biológica; Humanos; Factores Inmunológicos; Estudios Prospectivos; Estudios Retrospectivos

Palabras clave

Cessation; Crohn's Disease; Deescalation; Treatment Discontinuation; Ulcerative Colitis; Withdrawal

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Colitis Ulcerosa / Enfermedad de Crohn Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Gastroenterol Hepatol Año: 2020 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google